MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Infectious Disease_Hepatitis
ENYO Pharma SA
Attachments
ENYO Pharma – Drug discovery inspired by viruses
Parents
*Architects: Gastroenterology_Gastrointestinal (to include Liver, Pancreas & metabolic dysfunction-associated steatotic liver disease (MASLD), Gout, MASH (Metabolic dysfunction-associated steatohepatitis), formerly, NASH (Non-Alcoholic SteatoHepatitis)Non-Alcoholic SteatoHepatitis (NASH)
*Architects: Infectious Disease_Hepatitis
Industry: France
Children
ENYO Pharma is a clinical stage Biotech with a unique drug discovery engine inspired by viruses.
Founded 2014
Lyon, France
The company has initiated three Phase 2 with its lead compound EYP001 (a non-Bile Acid FXR agonist) in Chronic Hepatitis B and in NASH
Jumps
89bio, Inc. (Nasdaq: ETNB)
CymaBay Therapeutics, Inc. (NASDAQ: CBAY)
Enanta Pharmaceuticals, Inc (NASDAQ: ENTA)*
Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT)
Metacrine, Inc. (NASDAQ: MTCR)
Terns Pharmaceuticals, Inc. (NASDAQ: TERN)*